姜虹 主任医师，讲师
硕士招生类型：专业型
硕士招生专业：肿瘤学
博士招生类型：
博士招生专业：
所在院系：附属同济医院
联系方式：Jianghong09126@126.com
课题组链接：
研究方向
主要任职
科研业绩

消化道肿瘤的综合诊治及基础研究
comprehensivetherapy and fundamental research of digestive system tumor

同济的学附属同济医院肿瘤内科 科主任
Chief of Department of Ocology of Tongji HospitalAffilated Tongji University
中国医师协会结直肠肿瘤内科专业委员会委员
Committeeof Internal Medcine section of Colorectal Oncology branch of Chinese Physician'sAssociation
上海市浦东新区肿瘤专业委员会委员
Memberof Oncology Specialized Committee of Pudong New Area, Shanghai


2000-2003
主要研究激活素A与肝纤维化的关系，探讨激活素A促进肝纤维化发生发展的机制，并检测肝硬化患者血清与腹水激活素A水平，提示其水平的变化与肝硬化相关，是一项鉴别良恶性腹水的潜在标记物。
2000-2003
Researchon the relationship between activin A and hepatic fibrosis. Based on the assayof serum and ascites activin A in patients with hepatic cirrhosis, discussedthe role of activin A in the occurrence and development of hepatic fibrosis,suggesting the correlation between the level of activin A and hepaticcirrhosis, indicating that activin A maybe a potential biomarker for benign andmalignant ascites.
2005-2008
进行临床试验，探讨同步放化疗在胃癌辅助治疗中的作用，证实同步放化疗减少T3-4胃癌患者术后局部复发率，延长PFS。
2005-2008
Clinicaltrials on the role of concurrent chemoradiotherapy in adjuvant treatment ofgastric cancer, proved that concurrent chemoradiotherapy reduced the localrecurrence rate and prolonged PFS in T3-4 gastric cancer patients.
2009-2014
糖组学在胰腺癌诊治中的应用研究。N-糖链在胰腺癌患者血清中的水平反映病情的变化，通过分析N-糖链不同成分的变化，探讨N-糖链作为胰腺癌早期诊断指标的可能性。
2009-2014
Applicationof glycomics in thediagnosis and treatment of pancreatic caner. The serum level of N-glycan inpancreatic cancer patient correlates with the variation of disease stage. Basedon the assay of different components of N-glycan, explore the possibility ofN-glycan as an diagnostic biomarker in early stage,
2012-2014
个体化诊断技术在结直肠癌患者诊治中的作用。通过基于基因检测基础上的个体化治疗，提高肿瘤治疗缓解率，降低毒副反应，建立结直肠癌精准治疗的理念。
2012-2014
Individualtherapy in the diagnosis and treatment of colorectal cancer. Individual therapybased on gene detection improves the remission rate of tumor and reducestocicity, establishing the concept of precise treatment for colorectal cancer.
2018-2020
获得市卫计委基金资助，主要研究外泌体FRLnc1作为胃癌早期诊断、疗效判断及预后分析的分子标志物。
2018-2020
Supportedby Shanghai Municipal Commission of Health and Family Planning, explore he roleof exosome FRLnc1 as an biomarker in the early diagnosis, efficacy evaluationand prognosis of gastric cancer.
在各类期刊共发表文章20余篇，其中SCI收录7篇。
承担省部级及市级课题各一项，参与各级课题多项。
Publishedmore than 20 articles in different journals, including 7 indexed by SCI.
Incharge of two projects supported by provincial and municipal, respectively.Participation in many projects at all levels.